Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 6Carcinoma, Non-Small-Cell Lung 5Neoplastic Cells, Circulating 4Neoplasm Metastasis 3Colorectal Neoplasms 3Prostatic Neoplasms 2Neuroendocrine Tumors 2Lung Neoplasms 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Ewing 1Salivary Gland Neoplasms 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1NSCLC 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Hematopoietic and Lymphoid System Neoplasm 1Head and Neck Neoplasms 1Glioma 1Disease 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colonic Neoplasms 1Carcinoma, Lobular 1

Interventions

Cyclophosphamide 25Temozolomide 22Vincristine 18Irinotecan 18Doxorubicin 13Topotecan 10Melphalan 10Etoposide 10Ifosfamide 8Busulfan 8cabozantinib 7Magnetic Resonance Spectroscopy 7Granulocyte Colony-Stimulating Factor 7Filgrastim 6regorafenib 5fludarabine 5X-Rays 5Specimen Handling 5Sirolimus 5Gemcitabine 5Drug Therapy 5pegfilgrastim 4palbociclib 4liposomal doxorubicin 4irinotecan sucrosofate 4fludarabine phosphate 4Trabectedin 4Radiotherapy 4Phantoms, Imaging 4Nivolumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Sarcoma, Ewing × Liquid Biopsy × Clear all
NCT06068075 2026-05-05

Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD

Dana-Farber Cancer Institute

Phase NA Active not recruiting
340 enrolled
Sarcoma

Sarcoma, Ewing, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡